AI-generated summary
The authors report a prospective open-label trial of 20 participants who received three treatments with a 1927-nm nonablative fractional diode laser around the eyes, at 2-week or 4-week intervals. Both groups showed improvements in lightness and pigmentation, and the 4-week group also showed greater wrinkle improvement, with transient side effects mostly resolving within 7 days. The small, open-label design limits how strongly these findings can be interpreted.
- Participants
- 20
- Who or what was studied
- Twenty participants undergoing periorbital rejuvenation treatment, randomized into two groups
- Wavelengths
- 1927 nm
- Limits stated in the abstract
- The study is small and open-label, and the abstract does not describe a sham or untreated control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
The 1927-nm nonablative fractional laser is widely used for skin rejuvenation and hyperpigmentation. However, its efficacy and safety for periorbital rejuvenation remain uncertain.
Aims
To assess the effects of the 1927-nm nonablative fractional diode laser on periorbital rejuvenation.
Patients/Methods
Twenty participants were randomized into two groups and received three treatments at 2-week (Group A) or 4-week (Group B) intervals. Clinical efficacy was assessed using ANTERA 3D, blinded investigator-rated scores, and subject self-assessments.
Results
Both group A and group B exhibited statistically significant improvements in L* (color measurement which indicates lightness) and pigmentation score at the end-of-study visit compared to baseline, with group B also achieving statistically significant enhancement in the pores' index and wrinkles' score. Group B showed greater improvement in wrinkles' score compared to group A at the end-of-study visit. The median of Global Aesthetic Improvement Scale assessed by both the physicians and subjects showed improvement, ranging from "improved" to "much improved" at the end-of-study visit. Transient side effects including tenderness, erythema, swelling, and scaling were observed, with the majority resolving within 7 days.
Conclusions
The 1927-nm diode laser is an effective and safe option for periorbital rejuvenation. The 4-week interval treatment appears to be the preferable option due to its superior improvement in the wrinkles' score at the end of the study. The positive changes in skin brightness and the reduction of brown spots represented additional benefits, setting it apart as a notable alternative to other ablative and nonablative fractional lasers.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.